Clinical Trial Update: The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining whether weight loss affects anti-Müllerian hormone levels in women with Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Polycystic Ovary Syndrome

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Obesity, Polycystic Ovaries Syndrome | Phase 4 | Status: UNKNOWN